These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8392970)

  • 41. [The cAMP system and bacterial toxins].
    Kather H; Aktories K
    Klin Wochenschr; 1983 Nov; 61(22):1109-14. PubMed ID: 6317939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of fluorescent chimeras of cholera toxin and Escherichia coli heat-labile enterotoxins produced by use of the twin arginine translocation system.
    Tinker JK; Erbe JL; Holmes RK
    Infect Immun; 2005 Jun; 73(6):3627-35. PubMed ID: 15908392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular transport and processing of protein toxins produced by enteric bacteria.
    Sandvig K; Garred O; van Deurs B
    Adv Exp Med Biol; 1997; 412():225-32. PubMed ID: 9192018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.
    Connell TD
    Expert Rev Vaccines; 2007 Oct; 6(5):821-34. PubMed ID: 17931161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gangliosides inhibit serological reactions for the detection of cholera and heat-labile enterotoxins of Escherichia coli.
    Ricci LC; de-Siqueira PS; Castro AF
    Braz J Med Biol Res; 1992; 25(8):805-7. PubMed ID: 1342612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No direct binding of the heat-labile enterotoxin of Escherichia coli to E. coli lipopolysaccharides.
    Jansson L; Angström J; Lebens M; Teneberg S
    Glycoconj J; 2010 Jan; 27(1):171-9. PubMed ID: 19844789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-immunoglobulin fraction of human milk protects rabbits against enterotoxin-induced intestinal fluid secretion.
    Otnaess AB; Svennerholm AM
    Infect Immun; 1982 Feb; 35(2):738-40. PubMed ID: 7056585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pathogenic activity modulation of Escherichia coli TL+ toxin with an isolated protein of Giardia intestinalis and a synthetic peptide].
    Jiménez-Cardoso E; Eligio-García L; Jiménez-Cardoso JM; Angeles-Anguiano E; Tobilla-Mercado JM; Castañeda G
    Rev Invest Clin; 2001; 53(4):340-5. PubMed ID: 11599482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid visual detection of Escherichia coli and Vibrio cholerae Heat-labile enterotoxins by nitrocellulose enzyme-linked immunosorbent assay.
    Beutin L; Bode L; Richter T; Peltre G; Stephan R
    J Clin Microbiol; 1984 Mar; 19(3):371-5. PubMed ID: 6371043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Escherichia coli cytotoxins and enterotoxins.
    Gyles CL
    Can J Microbiol; 1992 Jul; 38(7):734-46. PubMed ID: 1393838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of drugs on the response of a cell culture preparation to bacterial toxins.
    Giugliano LG; Drasar BS
    J Med Microbiol; 1984 Apr; 17(2):151-8. PubMed ID: 6142959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type II heat-labile enterotoxin of Escherichia coli activates adenylate cyclase in human fibroblasts by ADP ribosylation.
    Chang PP; Moss J; Twiddy EM; Holmes RK
    Infect Immun; 1987 Aug; 55(8):1854-8. PubMed ID: 3112012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides.
    Jacob CO; Arnon R; Finkelstein RA
    Infect Immun; 1986 May; 52(2):562-7. PubMed ID: 3009330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids.
    Bowman CC; Clements JD
    Infect Immun; 2001 Mar; 69(3):1528-35. PubMed ID: 11179323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea.
    Paton AW; Jennings MP; Morona R; Wang H; Focareta A; Roddam LF; Paton JC
    Gastroenterology; 2005 May; 128(5):1219-28. PubMed ID: 15887106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit.
    Matousek MP; Nedrud JG; Cieplak W; Harding CV
    Infect Immun; 1998 Jul; 66(7):3480-4. PubMed ID: 9632629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Grape extracts inhibit multiple events in the cell biology of cholera intoxication.
    Reddy S; Taylor M; Zhao M; Cherubin P; Geden S; Ray S; Francis D; Teter K
    PLoS One; 2013; 8(9):e73390. PubMed ID: 24039929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT).
    Merritt EA; Sixma TK; Kalk KH; van Zanten BA; Hol WG
    Mol Microbiol; 1994 Aug; 13(4):745-53. PubMed ID: 7997185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose.
    Uesaka Y; Otsuka Y; Lin Z; Yamasaki S; Yamaoka J; Kurazono H; Takeda Y
    Microb Pathog; 1994 Jan; 16(1):71-6. PubMed ID: 8057828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review).
    De Haan L; Hirst TR
    Mol Membr Biol; 2004; 21(2):77-92. PubMed ID: 15204437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.